Wagner’s migraine and other stories . . .BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2919 (Published 30 April 2014) Cite this as: BMJ 2014;348:g2919
All rapid responses
I agree with Minerva that intravenous Ketamine is not one to try at home for depression, or indeed chronic pain. However I would like to bring to Minerva's attention and to the attention of readers in general, my experience with using low dose sublingual ketamine in a heterogeneous group of patients with chronic pain, reflecting over 200 patient years of experience of using this treatment modality and something that these patients do use at home. By reading the paper you will see that whilst sublingual ketamine treatment is a therapy that is not consistently helpful, for a small group of patients, it does appear to afford some symptom relief.
 Jaitly V. Sublingual Ketamine in chronic pain: Service evaluation by examining over 200 patient years of data. Journal of Observational Pain Medicine – Volume 1, Number 2 (2013) ISSN 2047-0800 (open access)
(last accessed 16 2 14)
Competing interests: Over the years I have attended meetings and had lunches/dinners sponsored by a range of pharmaceutical firms and equipment manufacturers.